Literature DB >> 17637570

Vaccination and risk groups: how can we really protect the weakest?

Paolo Bonanni1.   

Abstract

Subjects who for their clinical conditions, age, occupational activities or living situations, are at increased risk of acquiring preventable infectious diseases or suffering from their complications, are the object of periodical attempts of identification and offer of vaccination. Several examples can be drawn from the past and from more recent experiences showing that targeted vaccination strategies usually fail to reach most of these subjects. As a matter of fact, obtaining a very high vaccination coverage in risk groups implies a complex integration of responsibilities in identifying, contacting, communicating with and immunizing many different categories of subjects. On the contrary, routine vaccination strategies of one or more cohorts of subjects have always shown the ability (if well implemented) to protect the weakest individuals in the community, due to the establishment of such a community protection as to get a remarkable positive impact even on those that are not immunized. It is ethically unsustainable that universal immunization strategies for diseases with remarkable impact and severity are delayed until an adequate coverage has been reached in subjects at risk, because this would paradoxically mean a serious damage just for those people that are the theoretical object of protection efforts through targeted vaccination strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17637570     DOI: 10.4161/hv.3.5.4351

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  3 in total

1.  Pneumococcal and influenza vaccination rates and their determinants in children with chronic medical conditions.

Authors:  Antonietta Giannattasio; Veronica Squeglia; Andrea Lo Vecchio; Maria Teresa Russo; Alessandro Barbarino; Raffaella Carlomagno; Alfredo Guarino
Journal:  Ital J Pediatr       Date:  2010-03-26       Impact factor: 2.638

Review 2.  Human papilloma virus vaccination: impact and recommendations across the world.

Authors:  Paolo Bonanni; Angela Bechini; Rosa Donato; Raffaella Capei; Cristiana Sacco; Miriam Levi; Sara Boccalini
Journal:  Ther Adv Vaccines       Date:  2015-01

3.  The effect of physician's recommendation on seasonal influenza immunization in children with chronic diseases.

Authors:  Elisabetta Pandolfi; Maria Giulia Marino; Emanuela Carloni; Mariateresa Romano; Francesco Gesualdo; Piero Borgia; Roberto Carloni; Alfredo Guarino; Antonietta Giannattasio; Alberto E Tozzi
Journal:  BMC Public Health       Date:  2012-11-15       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.